🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Robin Hilder

University of California, Los Angeles

ORCID: 0000-0001-9927-6792

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Safety and efficacy of immune checkpoint inhibitor cancer therapy in patients with preexisting type 1 diabetes mellitus”.

Safety and efficacy of immune checkpoint inhibitor cancer therapy in patients with preexisting type 1 diabetes mellitus

Frontiers in Endocrinology(2023)10.3389/fendo.2023.1242830

N/A

0.312DataRank · unranked

7 citations

Karen Tsai, Zoe Quandt, Dayna J Isaacs, Alexandra Drakaki, Yan Xing +4 more

A community-partnered approach for diversity in COVID-19 vaccine clinical trials

Journal of Clinical and Translational Science(2022)10.1017/cts.2022.471

N/A

0DataRank · unranked

16 citations

Raphael J. Landovitz, Ejiro Ntekume, Courtney Porter, Rachelle Bross, Robin Hilder +10 more

Are severe immune-related adverse events more likely in patients with pre-existing autoimmune disease?

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e14599

N/A

0DataRank · unranked

0 citations

Robin Hilder, Alexandra Drakaki, Melissa G. Lechner, Dayna J Isaacs